The University of Chicago Header Logo

Connection

Arthur Herbst to Pregnancy

Back to Details
This is a "connection" page, showing publications Arthur Herbst has written about Pregnancy.
Arthur Herbst
Connection Strength
1.284
Pregnancy
  1. Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix. N Engl J Med. 2018 05 03; 378(18):1746-1748.
    View in: PubMed
    Score: 0.097
  2. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up. Gynecol Oncol. 2017 09; 146(3):566-571.
    View in: PubMed
    Score: 0.091
  3. Diethylstilbestrol (DES) Pregnancy Treatment: A Promising Widely Used Therapy with Unintended Adverse Consequences. AMA J Ethics. 2015 Sep 01; 17(9):865-70.
    View in: PubMed
    Score: 0.080
  4. Influence of mode of delivery on neonatal mortality in the second twin, at and before term. BJOG. 2008 Nov; 115(12):1512-7.
    View in: PubMed
    Score: 0.050
  5. Diethylstilbestrol and other sex hormones during pregnancy. Obstet Gynecol. 1981 Nov; 58(5 Suppl):35S-40S.
    View in: PubMed
    Score: 0.031
  6. Risk factors for diethylstilbestrol-associated clear cell adenocarcinoma. Obstet Gynecol. 2000 Jun; 95(6 Pt 1):814-20.
    View in: PubMed
    Score: 0.028
  7. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES). Gynecol Oncol. 2000 Feb; 76(2):147-56.
    View in: PubMed
    Score: 0.027
  8. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971. Am J Obstet Gynecol. 1999 Dec; 181(6):1574-5.
    View in: PubMed
    Score: 0.027
  9. Diethylstilbestrol and adenocarcinoma of the vagina. Am J Obstet Gynecol. 1999 Dec; 181(6):1576-8; discussion 1579.
    View in: PubMed
    Score: 0.027
  10. Reproductive and hormone-related outcomes in women whose mothers were exposed in utero to diethylstilbestrol (DES): A report from the US National Cancer Institute DES Third Generation Study. Reprod Toxicol. 2019 03; 84:32-38.
    View in: PubMed
    Score: 0.025
  11. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract. Am J Obstet Gynecol. 2016 09; 215(3):322.e1-8.
    View in: PubMed
    Score: 0.021
  12. Self-reported allergy, infection, and autoimmune diseases among men and women exposed in utero to diethylstilbestrol. J Clin Epidemiol. 1996 Feb; 49(2):263-6.
    View in: PubMed
    Score: 0.021
  13. Risk factors for fever in labor. Obstet Gynecol. 1995 Nov; 86(5):790-4.
    View in: PubMed
    Score: 0.020
  14. Age at menarche among diethylstilbestrol granddaughters. Am J Obstet Gynecol. 1995 Sep; 173(3 Pt 1):835-6.
    View in: PubMed
    Score: 0.020
  15. Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med. 1995 May 25; 332(21):1411-6.
    View in: PubMed
    Score: 0.020
  16. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt). 2015 Apr; 24(4):308-15.
    View in: PubMed
    Score: 0.019
  17. Onset of menopause in women exposed to diethylstilbestrol in utero. Am J Obstet Gynecol. 1995 Jan; 172(1 Pt 1):92-5.
    View in: PubMed
    Score: 0.019
  18. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma. Gynecol Oncol. 1994 Nov; 55(2):238-44.
    View in: PubMed
    Score: 0.019
  19. DES exposure: an update. Contemp Pediatr. 1994 Nov; 11(11):59-62, 64, 66 passim.
    View in: PubMed
    Score: 0.019
  20. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet Gynecol. 1994 Sep; 84(3):404-8.
    View in: PubMed
    Score: 0.019
  21. Effects on the menstrual cycle of in utero exposure to diethylstilbestrol. Am J Obstet Gynecol. 1994 Mar; 170(3):709-15.
    View in: PubMed
    Score: 0.018
  22. Impact of contraception on gynecologic cancers. Am J Obstet Gynecol. 1993 Jun; 168(6 Pt 2):1980-5.
    View in: PubMed
    Score: 0.017
  23. Medical conditions among adult offspring prenatally exposed to diethylstilbestrol. Epidemiology. 2013 May; 24(3):430-8.
    View in: PubMed
    Score: 0.017
  24. Prenatal diethylstilbestrol exposure and performance on college entrance examinations. Horm Behav. 1992 Sep; 26(3):433-9.
    View in: PubMed
    Score: 0.016
  25. Does early exposure to maternal smoking affect future fertility in adult males? Reprod Toxicol. 1992; 6(4):297-307.
    View in: PubMed
    Score: 0.016
  26. Mammography screening behaviors of women exposed prenatally to diethylstilbestrol. J Womens Health (Larchmt). 2012 Feb; 21(2):209-14.
    View in: PubMed
    Score: 0.016
  27. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med. 2011 Oct 06; 365(14):1304-14.
    View in: PubMed
    Score: 0.015
  28. Clear cell adenocarcinoma of the lower genital tract. Correlation of mother's recall of diethylstilbestrol history with obstetrical records. Cancer. 1990 Nov 15; 66(10):2215-20.
    View in: PubMed
    Score: 0.014
  29. Medical professional liability and obstetric care: the Institute of Medicine report and recommendations. Obstet Gynecol. 1990 Apr; 75(4):705-9.
    View in: PubMed
    Score: 0.014
  30. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Semin Surg Oncol. 1990; 6(6):343-6.
    View in: PubMed
    Score: 0.014
  31. Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ Health. 2009 Aug 18; 8:37.
    View in: PubMed
    Score: 0.013
  32. Breast cancer screening in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt). 2009 Apr; 18(4):547-52.
    View in: PubMed
    Score: 0.013
  33. Infertility among daughters either exposed or not exposed to diethylstilbestrol. Am J Obstet Gynecol. 1988 Mar; 158(3 Pt 1):493-8.
    View in: PubMed
    Score: 0.012
  34. Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation. Epidemiology. 2008 Mar; 19(2):251-7.
    View in: PubMed
    Score: 0.012
  35. Secondary sex ratio among women exposed to diethylstilbestrol in utero. Environ Health Perspect. 2007 Sep; 115(9):1314-9.
    View in: PubMed
    Score: 0.012
  36. Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer. 2007 Jul 15; 121(2):356-60.
    View in: PubMed
    Score: 0.011
  37. Preeclampsia risk in women exposed in utero to diethylstilbestrol. Obstet Gynecol. 2007 Jul; 110(1):113-20.
    View in: PubMed
    Score: 0.011
  38. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N Engl J Med. 1987 Feb 26; 316(9):514-6.
    View in: PubMed
    Score: 0.011
  39. The effects in the human of diethylstilbestrol (DES) use during pregnancy. Princess Takamatsu Symp. 1987; 18:67-75.
    View in: PubMed
    Score: 0.011
  40. Age at natural menopause in women exposed to diethylstilbestrol in utero. Am J Epidemiol. 2006 Oct 01; 164(7):682-8.
    View in: PubMed
    Score: 0.011
  41. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1509-14.
    View in: PubMed
    Score: 0.011
  42. Mortality in women given diethylstilbestrol during pregnancy. Br J Cancer. 2006 Jul 03; 95(1):107-11.
    View in: PubMed
    Score: 0.011
  43. Birth weight and breast cancer risk. Br J Cancer. 2006 Jun 05; 94(11):1734-7.
    View in: PubMed
    Score: 0.011
  44. Clear cell adenocarcinoma (CCA) of the vagina and cervix in association with pregnancy. Gynecol Oncol. 1986 Jun; 24(2):207-19.
    View in: PubMed
    Score: 0.011
  45. Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES). Int J Epidemiol. 2006 Aug; 35(4):862-8.
    View in: PubMed
    Score: 0.011
  46. Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: a case-control study. Am J Obstet Gynecol. 1986 Apr; 154(4):814-22.
    View in: PubMed
    Score: 0.010
  47. Hypospadias in sons of women exposed to diethylstilbestrol in utero. Epidemiology. 2005 Jul; 16(4):583-6.
    View in: PubMed
    Score: 0.010
  48. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure. Obstet Gynecol. 2005 Jan; 105(1):167-73.
    View in: PubMed
    Score: 0.010
  49. Diethylstilbestrol exposure--1984. N Engl J Med. 1984 Nov 29; 311(22):1433-5.
    View in: PubMed
    Score: 0.010
  50. Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States). Cancer Causes Control. 2002 Oct; 13(8):753-8.
    View in: PubMed
    Score: 0.008
  51. Reproductive and gynecologic surgical experience in diethylstilbestrol-exposed daughters. Am J Obstet Gynecol. 1981 Dec 15; 141(8):1019-28.
    View in: PubMed
    Score: 0.008
  52. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control. 2001 Nov; 12(9):837-45.
    View in: PubMed
    Score: 0.008
  53. Infertility among women exposed prenatally to diethylstilbestrol. Am J Epidemiol. 2001 Aug 15; 154(4):316-21.
    View in: PubMed
    Score: 0.008
  54. Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer. 1981 Jul 15; 48(2 Suppl):484-8.
    View in: PubMed
    Score: 0.008
  55. Intrauterine infection may be a major cause of stillbirth in Sweden. Acta Obstet Gynecol Scand. 2001 Jun; 80(6):511-8.
    View in: PubMed
    Score: 0.007
  56. Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst. 2001 Apr 04; 93(7):545-51.
    View in: PubMed
    Score: 0.007
  57. The current status of the DES-exposed population. Obstet Gynecol Annu. 1981; 10:267-78.
    View in: PubMed
    Score: 0.007
  58. DES update. Interview by Arthur I. Holleb. CA Cancer J Clin. 1980 Nov-Dec; 30(6):326-32.
    View in: PubMed
    Score: 0.007
  59. Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring. Obstet Gynecol. 2000 Oct; 96(4):483-9.
    View in: PubMed
    Score: 0.007
  60. A comparison of pregnancy experience in DES-exposed and DES-unexposed daughters. J Reprod Med. 1980 Feb; 24(2):62-9.
    View in: PubMed
    Score: 0.007
  61. Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1979 Dec 01; 135(7):876-86.
    View in: PubMed
    Score: 0.007
  62. Coitus and the fetus. N Engl J Med. 1979 Nov 29; 301(22):1235-6.
    View in: PubMed
    Score: 0.007
  63. DES-associated clear cell adenocarcinoma of the vagina and cervix. Obstet Gynecol Surv. 1979 Nov; 34(11):844.
    View in: PubMed
    Score: 0.007
  64. A correlative nuclear DNA and histologic study of genital squamous lesions in DES exposed progeny. Obstet Gynecol Surv. 1979 Nov; 34(11):849-50.
    View in: PubMed
    Score: 0.007
  65. Prenatal diethylstilbestrol exposure and human genital tract abnormalities. Natl Cancer Inst Monogr. 1979 May; (51):25-35.
    View in: PubMed
    Score: 0.006
  66. Complications of prenatal therapy with diethylstilbestrol. Pediatrics. 1978 Dec; 62(6 Pt 2):1151-9.
    View in: PubMed
    Score: 0.006
  67. A twenty-five-year follow-up study of women exposed to diethylstilbestrol during pregnancy. N Engl J Med. 1978 Apr 06; 298(14):763-7.
    View in: PubMed
    Score: 0.006
  68. Evaluation and management of diethylstilbestrol-exposed offspring. Surg Clin North Am. 1978 Feb; 58(1):87-96.
    View in: PubMed
    Score: 0.006
  69. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1977 May 01; 128(1):43-50.
    View in: PubMed
    Score: 0.006
  70. Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero. Cancer. 1977 Apr; 39(4 Suppl):1892-5.
    View in: PubMed
    Score: 0.006
  71. Cytology of 575 young women with prenatal exposure to diethylstilbestrol. Obstet Gynecol. 1976 Nov; 48(5):511-5.
    View in: PubMed
    Score: 0.005
  72. Nuclear chromatin determination in amniotic fluid cells for prenatal sex prediction in the macaque. Am J Obstet Gynecol. 1976 Apr 01; 124(7):761-3.
    View in: PubMed
    Score: 0.005
  73. Summary of the changes in the human female genital tract as a consequence of maternal diethylstilbestrol therapy. J Toxicol Environ Health Suppl. 1976; 1:13-20.
    View in: PubMed
    Score: 0.005
  74. Vaginal adenosis and other diethylstilbestrol-related abnormalities. Clin Obstet Gynecol. 1975 Sep; 18(3):185-94.
    View in: PubMed
    Score: 0.005
  75. Editorial: Problems in the examination of the DES-exposed female. Obstet Gynecol. 1975 Sep; 46(3):353-5.
    View in: PubMed
    Score: 0.005
  76. Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls. N Engl J Med. 1975 Feb 13; 292(7):334-9.
    View in: PubMed
    Score: 0.005
  77. Delayed disease as a consequence of fetal exposure to radiation, infection, and exogenous hormones. Clin Perinatol. 1974 Sep; 1(2):483-90.
    View in: PubMed
    Score: 0.005
  78. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol. Ann Clin Lab Sci. 1974 Jul-Aug; 4(4):222-33.
    View in: PubMed
    Score: 0.005
  79. Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol. 1974 Jul 01; 119(5):713-24.
    View in: PubMed
    Score: 0.005
  80. The effects of local progesterone on stilbestrol-associated vaginal adenosis. Am J Obstet Gynecol. 1974 Mar 01; 118(5):607-15.
    View in: PubMed
    Score: 0.005
  81. Exogenous hormones in pregnancy. Clin Obstet Gynecol. 1973 Dec; 16(4):37-50.
    View in: PubMed
    Score: 0.004
  82. Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am J Obstet Gynecol. 1993 Nov; 169(5):1119-24.
    View in: PubMed
    Score: 0.004
  83. Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med. 1972 Dec 21; 287(25):1259-64.
    View in: PubMed
    Score: 0.004
  84. Stilbestrol and vaginal cancer in young women. CA Cancer J Clin. 1972 Sep-Oct; 22(5):292-5.
    View in: PubMed
    Score: 0.004
  85. Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Obstet Gynecol. 1972 Sep; 40(3):287-98.
    View in: PubMed
    Score: 0.004
  86. Stilbestrol-adenosis-carcinoma syndrome: geographic distribution. N Engl J Med. 1971 Sep 16; 285(12):691.
    View in: PubMed
    Score: 0.004
  87. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 04 22; 284(15):878-81.
    View in: PubMed
    Score: 0.004
  88. Hyperthyroidism during pregnancy. N Engl J Med. 1965 Sep 16; 273(12):627-33.
    View in: PubMed
    Score: 0.003
  89. Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. Cancer. 1984 Sep 01; 54(5):869-75.
    View in: PubMed
    Score: 0.002
  90. Combined antithyroid-thyroid therapy of hyperthyroidism in pregnancy. Obstet Gynecol. 1963 May; 21:543-50.
    View in: PubMed
    Score: 0.002
  91. Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol. 1978 Apr; 51(4):453-8.
    View in: PubMed
    Score: 0.002
  92. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. Cancer Res. 1977 Apr; 37(4):1249-51.
    View in: PubMed
    Score: 0.001
  93. Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. Cancer. 1974 Sep; 34(3):606-14.
    View in: PubMed
    Score: 0.001
  94. Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. Acta Cytol. 1974 Jul-Aug; 18(4):279-90.
    View in: PubMed
    Score: 0.001
  95. Registry of clear-cell carcinoma of genital tract in young women. N Engl J Med. 1971 Aug 12; 285(7):407.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.